Rapid improvement of retinal and iris neovascularization after a single intravitreal bevacizumab injection in a patient with central retinal vein occlusion and neovascular glaucoma-Reference-Cited by-同舟云学术

Rapid improvement of retinal and iris neovascularization after a single intravitreal bevacizumab injection in a patient with central retinal vein occlusion and neovascular glaucoma

Published:2007-07-04 Issue:1 Volume:28 Page:59-61
ISSN:0165-5701
Container-title:International Ophthalmology
language:en
Short-container-title:Int Ophthalmol

Author:

Batioğlu Figen,Astam Neslihan,Özmert Emin

Publisher

Springer Science and Business Media LLC

Subject

Ophthalmology

Link

http://link.springer.com/content/pdf/10.1007/s10792-007-9105-2.pdf

Reference13 articles.

1. Ferrara N (2004) Vascular endothelial growth factor: basic science in clinical progress. Endocrinol Rev 25:581–611

2. Kabbinavar E, Hurwitz HI, Fehrenbacher L et al (2003) Phase II, randomized trial comparing bevacizumab plus fluorouracil (FU)/leucovorin (LV)with FU/LV alone in patients with metastatic colorectal cancer. J Clin Oncol 21:60–65

3. Michels S, Rosenfeld PJ, Puliafito CA et al (2005) Systemic bevacizumab (Avastin) for neovascular age-related macular degeneration: twelve-week results of an uncontrolled open-label therapy. Ophthalmology 36:270–271

4. Rosenfeld PJ, Moshfeghi AA, Puliafito CA (2005) Optical coherence tomography findings after intravitreal injection of bevacizumab (Avastin®) for neovascular age-related macular degeneration. Ophthalmic Surg Lasers Imaging 36:331–335

5. Rosenfeld PJ, Fung AE, Puliafito CA (2005) Optical coherence tomography findings after an intravitreal injection of bevacizumab (Avastin) for macular edema from central retinal vein occlusion. Ophthalmic Surg Lasers and Imaging 36:336–339

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of angiogenesis inhibitors on the postoperative course of Ahmed valve implantation in patients with neovascular glaucoma;National Journal glaucoma;2022-11-24

2. Anti-Vascular Endothelial Growth Factor for Neovascular Glaucoma;Essentials in Ophthalmology;2022

3. A prospective, randomised, placebo-controlled, double-masked, three-armed, multicentre phase II/III trial for the Study of a Topical Treatment of Ischaemic Central Retinal Vein Occlusion to Prevent Neovascular Glaucoma – the STRONG study: study protocol for a randomised controlled trial;Trials;2017-03-16

4. Central Retinal Vein Occlusion;Ocular Vascular Occlusive Disorders;2014-12-08

5. Efficacy and safety of intravitreal bevacizumab in eyes with neovascular glaucoma undergoing ahmed glaucoma valve implantation: 2-year follow-up;Acta Ophthalmologica;2014-07-02